Clinical relevance of increased retinoid and cAMP transcriptional programs in tumor cells rendered non-malignant by dominant negative inhibition of NFκB
- 8 May 2003
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 194 (1) , 37-43
- https://doi.org/10.1016/s0304-3835(03)00053-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Contributions of mitogen-activated protein kinase and nuclear factor kappa B toN-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cellsMolecular Carcinogenesis, 2002
- Suppression of apoptosis: role in cell growth and neoplasiaLeukemia, 2001
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJournal of Clinical Investigation, 2001
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Nuclear Factor-κB-dependent Gene Activation at Multiple Levels in the Human Monocytic Cell Line THP-1Journal of Biological Chemistry, 2001
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Retinoids Inhibit Interleukin-12 Production in Macrophages through Physical Associations of Retinoid X Receptor and NFκBJournal of Biological Chemistry, 1999
- Innovative treatment programs against cancerBiochemical Pharmacology, 1999
- Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.Journal of Clinical Investigation, 1997
- Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial CellsJournal of Biological Chemistry, 1996
- Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: The use of site-selective cAMP analogs, antisense strategy, and gene transferLife Sciences, 1991